Calgary-based Ocumetics Technology Corp. announced today that it has commenced manufacturing its cutting-edge intraocular lenses for a groundbreaking first-in-human study, set to take place in the Dominican Republic.
Ocumetics’ lens technology is engineered to offer an accommodating intraocular lens designed to fit within the lens capsule, effectively eliminating the need for corrective lenses. This innovation harnesses the natural kinetics of the eye’s ciliary muscles and zonules.
The proprietary design of these lenses is intended not only as a replaceable device but also as a docking station for customized optics and evolving nanotechnologies.
Dean Burns, CEO of Ocumetics, expressed enthusiasm about the partnership with Bioana, stating, “We are thrilled to collaborate with Bioana, utilizing their medical device expertise and advanced manufacturing facilities to bring our innovative intraocular lenses to fruition. This production milestone is a key step in our mission to provide enhanced vision clarity for patients following cataract surgery.”
The Ocumetics lenses are poised to revolutionize vision correction technology, offering superior visual acuity at all distances and significantly improving the quality of life for users. The forthcoming clinical study in the Dominican Republic will assess these lenses in a real-world medical setting.
Bioana, a leading design and development firm based in Monterrey, Mexico, will spearhead the initial production run. Adriana Torres, COO and Chief Engineer at Bioana, commented, “We are honored to be selected by Ocumetics for this pivotal project. Our team is eager to apply our extensive experience in medical device manufacturing to support Ocumetics in transforming eye care.”
The Dominican Republic study represents a crucial phase in the lens development process. It will provide essential data on the performance and safety of the Ocumetics lenses, as the company seeks regulatory approval for its new accommodating intraocular lenses.
Related topics:
